The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prediction of metastatic castrate-resistant prostate cancer response to abiraterone or enzalutamide by a baseline blood-based CTC gene expression signature.
 
Michael Joseph Lariviere
No Relationships to Disclose
 
Naomi B. Haas
Consulting or Advisory Role - Cerulean Pharma; Exelixis; Janssen Oncology; Novartis; Pfizer
Expert Testimony - Lilly (I)
 
Yauheniya Cherkas
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson
 
Karl Nielsen
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson
 
Brad Foulk
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson
Patents, Royalties, Other Intellectual Property - Janssen Research & Development; Menarini Silicon Biosystems
 
Jaymala Patel
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson
 
Denis Smirnov
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson
 
David J. Vaughn
Consulting or Advisory Role - Merck Sharp & Dohme
Research Funding - Astellas Pharma; Merck Sharp & Dohme; Roche/Genentech
 
Ravi K. Amaravadi
Leadership - Pinpoint Therapeutics
Consulting or Advisory Role - Immunaccel; Sprint Bioscience
 
Samantha L. Savitch
No Relationships to Disclose
 
Krishna Majmundar
No Relationships to Disclose
 
Thomas H. Buckingham
No Relationships to Disclose
 
Stephanie S. Yee
No Relationships to Disclose
 
Jeremy Jones
No Relationships to Disclose
 
Sumanta K. Pal
Honoraria - Astellas Pharma; Medivation; Novartis
Consulting or Advisory Role - Astellas Pharma; Aveo; Bristol-Myers Squibb; Eisai; Exelixis; Genentech; Ipsen; Myriad Pharmaceuticals; Novartis; Pfizer
Research Funding - Medivation
 
Erica L. Carpenter
Honoraria - AstraZeneca
Research Funding - Becton Dickinson; Janssen; Merck
Patents, Royalties, Other Intellectual Property - Invention disclosure entitled, "Methods and Compositions for Identifying, Diagnosing and Treating Neuroblastoma"; Invention disclosure entitled, "Methods and Compositions for Identifying, Diagnosing and Treating Neuroblastoma"; Invention disclosure entitled, "Methods and Compositions for Treating Neuroblastoma"
Travel, Accommodations, Expenses - AstraZeneca; Foundation Medicine